It was placed on FDA's 503A Category 2 list of bulk substances flagged for compounding safety risks in September 2023 and removed from that list on April 23, 2026 after the underlying nominations were withdrawn
Available in 2mg, 5mg and 10mg vials
It can compromise the integrity of painstakingly synthesized peptides, introduce variables you can't account for, and ultimately render your data useless
When combined with semaglutide 2.4mg in the Phase 1b combination trial, the pairing produced 17.1% weight reduction
PMID: 110 Di RosaCAltomareATerrignoVCarboneFTackJCicalaMet al
After six visits and a negative gastrointestinal workup, an astute resident finally asked about menstrual timing and referred her to gynecology, leading to an endometriosis diagnosis